04.03.2014 • News

Bayer Teams up with GreenLight on Sustainable Feedstocks

GreenLight Biosciences and Bayer CropScience have established a new partnership to explore applications of GreenLight's proprietary cell-free technologies to increase the productivity of potential manufacturing processes.

Financial terms of the agreement were not disclosed.

The Boston, Massachusetts-based biotech firm is developing ways of manufacturing crop protection products through bacteria, which have been engineered to produce enzymes for chemical synthesis processes.

CEO Andrey Zarur said his company wants "to be at the forefront of creating new, non-petroleum based processes. Specifically we aim to replace the use of fossil hydrocarbons and expensive natural precursors in the production of chemicals with sustainable feedstocks."

GreenLight said the "unique partnership" with Bayer "will couple the potential of our cell-free platform for efficient manufacturing with the "remarkable innovations" of the German chemical giant.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.